The reticuloendothelial system in scrapie pathogenesis

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Scrapie is a fatal neurodegenerative disease caused by prions.
• The lymphoreticular system plays a role in scrapie pathogenesis.
• Current treatments for prion diseases are limited.

Purpose of the Study:

• To investigate the therapeutic potential of dextran sulphate 500 in scrapie infection.
• To determine the effect of dextran sulphate 500 on scrapie incubation time and survival.
• To explore the mechanism of action of dextran sulphate 500 in scrapie-infected mice.

Main Methods:

• Mice were infected with scrapie via intravenous or intraperitoneal routes.
• A single injection of dextran sulphate 500 (1 mg/mouse) was administered at various time points post-infection.
• Incubation times and survival rates were monitored.
• The distribution of dextran sulphate 500 in tissues was analyzed.
• The reticuloendothelial system was blocked using trypan blue and silica to assess its role.

Main Results:

• Dextran sulphate 500 significantly prolonged scrapie incubation times and increased survival rates.
• Therapeutic effects were observed even when dextran sulphate 500 was administered 3 days post-infection.
• Dextran sulphate 500 was detected in mononuclear phagocytes of the spleen and lymph nodes for up to 7 months.
• Blockage of the reticuloendothelial system did not affect scrapie pathogenesis.

Conclusions:

• Dextran sulphate 500 demonstrates significant therapeutic potential against scrapie infection in mice.
• The compound likely impairs a critical step in the scrapie infectious process within lymphoreticular cells.
• Further research is warranted to elucidate the precise mechanism and clinical applicability of dextran sulphate 500 for prion diseases.